Skip to main content
Caplight Logo









CoreBone

CoreBone

Private
IsraelHealthcare & Life Scienceshttps://core-bone.com

Last Round

Series A

Oct 4, 2021

Total Funding Raised

$4.04M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

CoreBone operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Series A round in October 2021.

CoreBone is a health tech company that develops and manufactures bioactive, coral-based bone graft materials for dental and orthopedic applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CoreBone Comparables

Compare CoreBone with similar companies based on industry and business-model similarity.

CoreBone comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zoan BioMed
84%
Marine Biomedical
83%
RevBio, Inc.
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CoreBone Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 4, 2021
CrowdfundingDec 29, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

CoreBone Investors

Notable investors and investment history

CoreBone investors
InvestorRounds
Guangzhou Biotechnology Investment FundSeries A
ExitValleyCrowdfunding
The Trendlines GroupSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 52% MoM.

  • Aug 21, 2026

    Monthly visitors increased 256% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

CoreBone Filings

Explore SEC and related filing metadata, where available.

CoreBone filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CoreBone's valuation, stock price, and market status.

Is CoreBone a public or private company?

CoreBone is a private company.

What is the current stock price of CoreBone?

CoreBone is a private company, so its shares have no public market price. Caplight tracks CoreBone's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CoreBone worth (valuation)?

Valuation information for CoreBone is not publicly available.

Can I buy CoreBone stock?

CoreBone shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CoreBone's last funding round?

CoreBone's most recent funding round was Series A on October 4, 2021.

Who are the main investors in CoreBone?

Key investors in CoreBone include Guangzhou Biotechnology Investment Fund.

Will CoreBone IPO soon?

No public IPO plans have been announced for CoreBone.

How can I track CoreBone secondary market activity?

Caplight tracks bids, offers, and trades in CoreBone's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range3
Year Founded2011
Last FundingOct 4, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?